Acute Respiratory Distress Syndrome News and Research

RSS

CSU chemists may help in making extracorporeal life support devices more effective

Smoke inhalation, pneumonia, and combat-related trauma are just a few causes of acute respiratory distress syndrome - a condition where the lungs fill with fluid, and is too often fatal.

24 Sep 2018

Study aims to investigate risk factors for PPCs in surgical patients with gastric cancer

As one of the most common malignant tumors, gastric cancer occupies the second leading cause of cancer-related deaths worldwide with an increasing trend.

18 Sep 2018

World Sepsis Day

A series of articles and thought leader interviews for World Sepsis Day on the 10th September 2018, aiming to raise awareness and improve understanding.

10 Sep 2018

Scientists develop three-pronged model to predict ARDS in burn patients

For the first time, researchers have devised a model to predict burn patients who are most likely to develop life-threatening acute respiratory distress syndrome.

28 Aug 2018

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.

23 Jul 2018

Study reveals new way to inhibit capillary leakage in sepsis

Leakage from the blood capillaries is a key mechanism leading to septic shock and multiorgan failure, which affect millions of patients annually worldwide. However, there is no effective way to inhibit the vessel leakiness. A new study by scientists at the University of Helsinki and Wihuri Research Institute demonstrates that vascular leakage can be inhibited by targeting vascular integrins.

25 Jun 2018

Researchers identify less-invasive treatment option for patients with ARDS

The numbers are grim: Of the 200,000 Americans diagnosed with Acute Respiratory Distress Syndrome each year, 30 to 50 percent will die.

6 Jun 2018

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

4 Jun 2018

Seniors' air pollution exposure linked to hospitalization for ARDS

In a new study, researchers found significant associations between seniors' long-term exposure to two types of air pollution and hospitalization for acute respiratory distress syndrome. The study was presented at the 2018 American Thoracic Society International Conference.

23 May 2018

BU postdoctoral researcher wins competitive NIH Pathway to Independence Award

Duo Zhang, PhD, a postdoctoral associate at Boston University School of Medicine, has received the highly competitive National Institutes of Health Pathway to Independence Award.

15 May 2018

Clinical trial to examine stem cell therapy for treatment, prevention of complications after traumatic injury

The University of Texas Health Science Center at Houston has received funding through a public/private partnership for the first-ever clinical trial investigating a stem cell therapy for early treatment and prevention of complications after severe traumatic injury.

23 Apr 2018

CReM researchers optimize process to engineer disease- or patient-specific lung stem cells

The Center for Regenerative Medicine at Boston University and Boston Medical Center has engineered two new categories of lung epithelial cells in vitro using pluripotent stem cells.

12 Apr 2018

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).

4 Dec 2017

Bulgaria reports outbreaks of bird flu (avian influenza)

Veterinary authorities in Bulgaria have called for culling of nearly 8,000 ducks according to a food safety agency yesterday after two more regions there have reported avian flu infection. According to the agency a total of four outbreaks of bird flu have been registered in Bulgaria at this time.

5 Nov 2017

Proton beam therapy can help improve outcomes in elderly patients with esophageal cancer

A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer.

25 Oct 2017

Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation

It has been amply proven that smoking can cause serious diseases such as emphysema and cancer. A new study, however, shows that pharmacological stimulation of a specific type of nicotinic receptor in cells of the immune system could be a strategy to treat inflammatory lung disease.

20 Oct 2017

Getinge announces next edition of ICU Experience for improving patient care

Getinge announces the next edition of the Intensive Care Unit (ICU) Experience which will take place in the Getinge Experience Center, Rastatt on Tuesday 19 September 2017. Over 50 customers from across Europe, Middle East & Africa will be in attendance and have the opportunity to network with scientific experts and medical device industry.

18 Sep 2017

ARDS survivors often leave hospital ICU with prolonged post-intensive care syndrome

Patients who survive acute respiratory distress syndrome (ARDS) often leave a hospital intensive care unit with debilitating mental, physical, or cognitive problems that may limit their quality of life.

24 Aug 2017

Hidden immune cells play key role in driving primary graft dysfunction

Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation.

15 Jun 2017

Study finds high volume ICUs to have lower mortality rates from ARDS

In a new study that analyzed data from the large French CUB-REA database, high volume intensive care units (ICUs) were found to have lower death rates from acute respiratory distress syndrome (ARDS) than low and moderate volume ICUs

22 May 2017